First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in myeloproliferative ...
Jung's shadow concept captures clinical reality. But the collective unconscious fails biologically. What should we keep, and what must go?
Prospective grammarians, folks, and foes of grammarland! Behold, the imposing peak of conjugation in front of you! Pray, with a firm step let’s advance mightily and prepare to scale yet another height ...
Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag ® payloads across multiple ADCs designed to address difficult-to-treat diseases Catalent’s preclinical study ...
The delivery of nucleic acids requires a gene vector as they are unable to effectively cross cell membranes. Polycations and deoxyribonucleic acid (DNA) can self-assemble into polyplexes enabling ...
EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The ...
Abstract: We present an all-optical stable quadruple frequency dissemination for an arbitrary-access-point fiber-optic loop link using photonic microwave phase conjugation. A two-tone optical carrier ...
Bioconjugation creates new molecules with increased stability and improved targeting. The process of joining proteins, peptides, or oligonucleotides to synthetic elements has produced drug conjugates ...
To adapt to changing environmental pressures, bacteria have developed various methods that allow them to uptake exogenous DNA and incorporate it into their own genomes. One of these processes is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results